NCT05992116Completed
Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction
The Prevalence of Iron Deficiency in Patients With Heart Failure (HFrEF and HFmrEF) in a Middle Eastern Population
Source: ClinicalTrials.gov · Last updated 25 Feb 2025
Brief summary (registry, in English)
A significant percentage of patients with heart failure and reduced ejection fraction (HFrEF) or mildly reduced ejection fraction (HFmrEF) have iron deficiency who are symptomatic. This is independently associated with bad quality of life, low functional capacity, lower quality of, life and increased mortality. The prevalence of iron deficiency in HFrEF and HFmrEF patients in Jordan has not been studied in the past.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 450 (actual)
- First submitted
- 8 Aug 2023
- Start date
- 1 Sept 2023
- Primary completion date
- 15 Jan 2025
- Lead sponsor
- Jordan Collaborating Cardiology Group
- Diseases
- Heart failure
- NCT number
- NCT05992116
What you commit to
- Study type: Observational
- Participants enrolled: 450
- From 1 Sept 2023 to the primary completion date, 15 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Oral or intravenous iron supplements within the previous 3 months; erythropoietin stimulating agents or blood transfusion within the last 6 months.
Other illness
- Acute coronary syndrome.
- Active clinically relevant bleeding in the investigator's opinion.
- Patients with chronic inflammatory conditions (e.g. rheumatoid arthritis; Crohn's disease, etc.); active infection; and decompensated liver disease.
Age
- Age\<18 years.
Other
- Known cases of iron overload (e.g. hemochromatosis); known cases of anemia due to other causes.
Who the study is looking for
- Heart failure patients with ejection fraction \<59% (including those with with reduced ejection fraction of ≤40%, or mildly reduced EF (41-49%)) within the last 2 years.
- NYHA class II-IV.
- Able and willing to provide oral informed consent.
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abdali Hospital Coordinator of this site? Confirm its status | Amman | Jordan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.